Issue 9/2013
Content (17 Articles)
Clinical and technical characteristics of intraoperative radiotherapy
M. Krengli, F.A. Calvo, F. Sedlmayer, C.V. Sole, G. Fastner, M. Alessandro, S. Maluta, R. Corvò, E. Sperk, M. Litoborski, C. Pisani, C. Fillini, F. Fusconi, M.F. Osti, L. Tomio, H. Marsiglia, A. Ciabattoni, W. Polkowski, A. Di Grazia, A. Gava, A. Kuten, C. Iotti, C. Gonzalez, M. Sallabanda, J.-B. Dubois, G. Catalano, V. Valentini
Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer
S.E. Combs, D. Habermehl, K. Kessel, F. Bergmann, J. Werner, I. Brecht, P. Schirmacher, D. Jäger, M.W. Büchler, J. Debus
Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer
P. Naumann, D. Habermehl, T. Welzel, J. Debus, S.E. Combs
Postoperative chemoradiotherapy following pancreaticoduodenectomy
K. Eom, E.K. Chie, K. Kim, J.J. Jang, S.W. Kim, D.Y. Oh, S.A. Im, T.Y. Kim, Y.J. Bang, S.W. Ha
Incidence and clinical course of radionecrosis in children with brain tumors
V. Strenger, H. Lackner, R. Mayer, P. Sminia, P. Sovinz, M. Mokry, A. Pilhatsch, M. Benesch, W. Schwinger, M. Seidel, D. Sperl, S. Schmidt, C. Urban
Adjuvant therapy after resection of brain metastases
J. Broemme, J. Abu-Isa, R. Kottke, J. Beck, R. Wiest, M. Malthaner, D. Schmidhalter, A. Raabe, D.M. Aebersold, A. Pica
Does high-dose radiotherapy benefit palliative lung cancer patients?
C. Schröder, M. Ivo, A. Buchali
A new survival score for patients with brain metastases from non-small cell lung cancer
D. Rades, L. Dziggel, B. Segedin, I. Oblak, V. Nagy, A. Marita, S.E. Schild, N.T. Trang, M.T. Khoa
Glycolysis-related gene induction and ATP reduction during fractionated irradiation
K. Goetze, S.S. Meyer, A. Yaromina, D. Zips, M. Baumann, W. Mueller-Klieser
Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
L. Van den Bergh, S. Isebaert, M. Koole, R. Oyen, S. Joniau, E. Lerut, C.M. Deroose, F. De Keyzer, H. Van Poppel, K. Haustermans
Treatment planning after hydrogel injection during radiotherapy of prostate cancer
M. Pinkawa, C. Bornemann, N. Escobar-Corral, M.D. Piroth, R. Holy, M.J. Eble
Langzeitverlauf der Lebensqualität nach Prostatektomie und perkutaner Strahlentherapie beim lokal begrenzten Prostatakarzinom
A. Simeonova, F. Wenz
Prädiktive Marker für die akute Normalgewebetoxizität bei Bestrahlung von nicht-kleinzelligen Lungenkarzinomen
E. Dikomey
Keine Verbesserung des Überlebens durch Induktionschemotherapie vor Radiochemotherapie beim fortgeschrittenen HNO-Tumor
S. Semrau